160 related articles for article (PubMed ID: 37445659)
21. Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review.
Ashrafizadeh M; Zarrabi A; Hushmandi K; Zarrin V; Moghadam ER; Hashemi F; Makvandi P; Samarghandian S; Khan H; Hashemi F; Najafi M; Mirzaei H
Front Pharmacol; 2020; 11():585413. PubMed ID: 33381035
[TBL] [Abstract][Full Text] [Related]
22. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.
Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G
Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464
[TBL] [Abstract][Full Text] [Related]
23. Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts.
Song K; Peng S; Sun Z; Li H; Yang R
Biochem Biophys Res Commun; 2011 Aug; 411(4):821-5. PubMed ID: 21798239
[TBL] [Abstract][Full Text] [Related]
24. Curcumin upregulates transforming growth factor-β1, its receptors, and vascular endothelial growth factor expressions in an in vitro human gingival fibroblast wound healing model.
Rujirachotiwat A; Suttamanatwong S
BMC Oral Health; 2021 Oct; 21(1):535. PubMed ID: 34657625
[TBL] [Abstract][Full Text] [Related]
25. Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β.
Nakayama N; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2011 Nov; 22(7):468-78. PubMed ID: 21968503
[TBL] [Abstract][Full Text] [Related]
26. Curcumin inhibits transforming growth factor-beta activity via inhibition of Smad signaling in HK-2 cells.
Hu Y; Liang H; Du Y; Zhu Y; Wang X
Am J Nephrol; 2010; 31(4):332-41. PubMed ID: 20160437
[TBL] [Abstract][Full Text] [Related]
27. Effect of curcumin on the expression of p53, transforming growth factor-β, and inducible nitric oxide synthase in oral submucous fibrosis: A pilot study.
Gupta S; Ghosh S; Gupta S; Sakhuja P
J Investig Clin Dent; 2017 Nov; 8(4):. PubMed ID: 27989010
[TBL] [Abstract][Full Text] [Related]
28. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
[TBL] [Abstract][Full Text] [Related]
29. Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts.
Zhang D; Huang C; Yang C; Liu RJ; Wang J; Niu J; Brömme D
Respir Res; 2011 Nov; 12(1):154. PubMed ID: 22126332
[TBL] [Abstract][Full Text] [Related]
30. Curcumin inhibits TGF-β1-induced connective tissue growth factor expression through the interruption of Smad2 signaling in human gingival fibroblasts.
Chen JT; Wang CY; Chen MH
J Formos Med Assoc; 2018 Dec; 117(12):1115-1123. PubMed ID: 29339038
[TBL] [Abstract][Full Text] [Related]
31. Proteasomal Degradation of Enhancer of Zeste Homologue 2 in Cholangiocytes Promotes Biliary Fibrosis.
Jalan-Sakrikar N; De Assuncao TM; Shi G; Aseem SO; Chi C; Shah VH; Huebert RC
Hepatology; 2019 Nov; 70(5):1674-1689. PubMed ID: 31070797
[TBL] [Abstract][Full Text] [Related]
32. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
33. [Effects of curcumin on the epithelial mesenchymal transition and TGF-beta/Smads signaling pathway in unilateral ureteral obstruction rats].
Li Y; Chen ZQ; Li YD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Sep; 31(9):1224-8. PubMed ID: 22013801
[TBL] [Abstract][Full Text] [Related]
34. Nanoformulation of a carbon monoxide releasing molecule protects against cyclosporin A-induced nephrotoxicity and renal fibrosis via the suppression of the NLRP3 inflammasome mediated TGF-β/Smad pathway.
Xia Z; Zhang C; Guo C; Song B; Hu W; Cui Y; Xue Y; Xia M; Xu D; Zhang S; Fang J
Acta Biomater; 2022 May; 144():42-53. PubMed ID: 35304324
[TBL] [Abstract][Full Text] [Related]
35. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
Guo L; Li H; Fan T; Ma Y; Wang L
Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats.
Yao QY; Xu BL; Wang JY; Liu HC; Zhang SC; Tu CT
BMC Complement Altern Med; 2012 Sep; 12():156. PubMed ID: 22978413
[TBL] [Abstract][Full Text] [Related]
37. Curcumin Targets p53-Fibrinolytic System in TGF-β1 Mediated Alveolar Epithelial Mesenchymal Transition in Alveolar Epithelial Cells.
Shaikh SB; Prabhu A; Bhandary YP
Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1441-1452. PubMed ID: 32990549
[TBL] [Abstract][Full Text] [Related]
38. Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing.
Mani H; Sidhu GS; Kumari R; Gaddipati JP; Seth P; Maheshwari RK
Biofactors; 2002; 16(1-2):29-43. PubMed ID: 12515914
[TBL] [Abstract][Full Text] [Related]
39. Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells.
Li R; Wang Y; Liu Y; Chen Q; Fu W; Wang H; Cai H; Peng W; Zhang X
PLoS One; 2013; 8(3):e58848. PubMed ID: 23544048
[TBL] [Abstract][Full Text] [Related]
40. WNT-5A regulates TGF-β-related activities in liver fibrosis.
Beljaars L; Daliri S; Dijkhuizen C; Poelstra K; Gosens R
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G219-G227. PubMed ID: 28057611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
